Status:
RECRUITING
Neopterin on Admission to Intensive Care Unit
Lead Sponsor:
Assistance Publique - Hôpitaux de Paris
Collaborating Sponsors:
Institut National de la Santé Et de la Recherche Médicale, France
Conditions:
Elderly Patient (80 Years Old or More) Admitted to Intensive Care
Eligibility:
All Genders
80+ years
Brief Summary
For the last twenty years, the proportion of patients aged 80 years and more, hospitalized in intensive care (ICU) has been increasing. The question of the admission of an elderly patient in intensive...
Eligibility Criteria
Inclusion
- Age ≥ 80 years old
- Admission to intensive care unit before 24 hours
- Non opposition expressed by the participant or its relative/trusty person, or emergency inclusion procedure
Exclusion
- Hospitalisation for a scheduled surgery
- New admission within a month before previous stay to intensive care unit
- Active solid cancer or malignant hemopathy
- Immunosuppressant treatment (including corticotherapy \> 5 mg/d)
- Autoimmune disease
- Tutorship or curatorship
Key Trial Info
Start Date :
November 21 2022
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2025
Estimated Enrollment :
326 Patients enrolled
Trial Details
Trial ID
NCT05233267
Start Date
November 21 2022
End Date
August 1 2025
Last Update
February 17 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hôpital Saint-Antoine / Service de réanimation
Paris, France, 75012